To identify new T-cell epitopes of classical swine fever virus (CSFV), 573 overlapping, synthetic pentadecapeptides spanning 82 % of the CSFV (strain Glentorf) genome sequence were synthesized and screened. In proliferation assays, 26 peptides distributed throughout the CSFV viral protein sequences were able to induce specific T-cell responses in PBMCs from a CSFVGlentorf-infected d/d haplotype pig. Of these 26 peptides, 18 were also recognized by PBMCs from a CSFV-Alfort/187-infected d/d haplotype pig. In further experiments, it could be shown that peptide 290 (KHKVRNEVMVHWFDD), which corresponds to amino acid residues 1446-1460 of the CSFV non-structural protein NS2-3 could induce interferon-γ secretion after secondary in vitro restimulation. The major histocompatibility complex (MHC) restriction for stimulation of T-cells by this pentadecapeptide was identified as being mainly MHC class II and partially MHC class I. In cytolytic assays, CSFV-specific cytotoxic T-lymphocytes (CTLs) were able to lyse peptide 290-loaded target cells. These findings indicate the existence of a CSFV-specific helper T-cell epitope and a CTL epitope in this peptide.
Introduction
Classical swine fever virus (CSFV), a highly contagious pestivirus of the family Flaviviridae (Wengler, 1991) , causes severe and lethal disease in domestic and wild pigs. The genome of CSFV consists of a positive-stranded RNA molecule of about 12n3 kb, which encodes a single open reading frame (ORF). The ORF is translated into a 3898 amino acid polyprotein (Meyers et al., 1989) , which gives rise to the different CSFV proteins after co-and post-translational processing. An autoprotease (N pro ) located at the N terminus of the polyprotein is followed by the structural proteins, core (C), E rns , E1 and E2, and the non-structural proteins, p7, NS2-3, NS4A, NS4B, NS5A and NS5B (Meyers & Thiel, 1996) .
Outbreaks of this disease occur frequently in several countries, usually with severe economic consequences (Edwards et al., 2000 ; Stegeman et al., 2000) . Vaccination based on lapinized C strains of CSFV and temperature-sensitive mutants are being used in many parts of the world (Aynaud, Author for correspondence : Armin Saalmu$ ller.
Fax j49 7071 967303. e-mail armin.saalmueller!tue.bfav.de 1988). However, these kinds of vaccines are prohibited from use within the European Union and several other countries due to the impossibility of differentiating between vaccinated and infected animals. In order to overcome the disadvantages of conventional vaccines, recombinant proteins (van Rijn et al., 1996) , virus vector vaccines (Ru$ menapf et al., 1991 ; van Zijl et al., 1991 ; Hooft van Iddekinge et al., 1996) , DNA vaccines (Andrew et al., 2000) and peptide vaccines (DiMarchi et al., 1986) have been proposed.
Synthetic peptides are promising candidate vaccines for the control of virus diseases. Peptide vaccines based on epitopes have been shown to induce a specific immune response (Deres et al., 1989) and to protect the host against the disease (Bittle et al., 1982 ; Menne et al., 1997 ; Wiesmu$ ller et al., 1989) . Thus, for the development of a synthetic peptide vaccine, characterization of the porcine immune response against CSFV is necessary. Studies on the cellular immune response to CSFV have been described previously (Kimman et al., 1993) . Viral proteins responsible for the induction of the virus-specific Tcell response were examined and a cytotoxic T-lymphocyte (CTL) epitope from the NS4A protein was identified . Also, the knowledge of allele-specific peptide motifs of major histocompatibility complex (MHC) class I (Falk et al., 1991) and class II (Falk et al., 1994) molecules is of great importance for the prediction and identification of speciesspecific T-cell epitopes. The use of synthetic, overlapping peptides that span the regions encoding the viral proteins is one of the strategies for the identification of T-cell epitopes (Muller et al., 1996 ; Blanco et al., 2001 ; Ober et al., 1998 ; Menne et al., 1997) . The aim of this study was to characterize the T-cell response to CSFV and to identify new CSFV T-cell epitopes using the cellular immune response of the natural host. A T-cell epitope mapping was performed with a set of 573 CSFV-derived, overlapping peptides spanning 82 % of the single ORF of the genome. Further experiments showed that a peptide derived from the NS2-3 protein contained a helper T-cell epitope as well as a CTL epitope in its sequence.
Methods
Infection of animals. Two d\d haplotype NIH miniature swine (Sachs et al., 1976) were infected by the intramuscular route (i.m.) with CSFV. Pig 1 was infected with 1i10% TCID &! CSFV strain Alfort\187 and pig 2 was infected with 1i10' TCID &! CSFV strain Glentorf. For the first and second challenge at monthly intervals, pig 1 was inoculated i.m. with 500 TCID &! CSFV-Alfort\187 and pig 2 with 1i10' TCID &! CSFV-Glentorf. Plasma and blood samples were collected before infection and eight times post-infection (p.i.).
Monoclonal antibodies (mAb).
Murine mAbs against porcine MHC class I (mAb 74-11-10, mouse IgG #b ) (Pescovitz et al., 1984) , MHC class II (mAb MSA3, mouse IgG #a ) (Hammerberg & Schurig, 1986 ) and CD4 (mAb 74-12-4, mouse IgG #b ) (Pescovitz et al., 1984) were kindly provided by J. K. Lunney (USDA, Agricultural Research Service, Beltsville, MD, USA). The porcine CD8 mAb (mAb 11\295\33, mouse IgG #a ) (Jonjic & Koszinowski, 1984) and mAb ' a18', a mouse IgG #a directed against glycoprotein E2 of CSFV (Weiland et al., 1990) , were established at the Federal Research Centre for Virus Diseases of Animals, Tu$ bingen, Germany.
Cells and viruses.
The Max cell line used as target cells for the cytotoxicity assays was established at the Federal Research Centre for Virus Diseases of Animals, Tu$ bingen, Germany. The cell line was grown in Dulbecco's modified Eagle's medium (DMEM) (Gibco BRL) supplemented with 10 % foetal calf serum (FCS), 2 mM -glutamine, 0n05 mM 2-mercaptoethanol, 10 mM HEPES (pH 7 . 2), 100 IU\ml penicillin and 0n1 mg\ml streptomycin sulphate. CSFV-Alfort\187 (Ruggli et al., 1996) and CSFV-Glentorf (Pittler et al., 1968) were a gift from R. Ahl, Federal Research Centre for Virus Diseases of Animals, Tu$ bingen, Germany. Both virus strains were propagated in the STE cell line (McClurkin & Norman, 1966) kindly provided by R. Ahl. Virus titres were determined by an indirect peroxidase-linked antibody assay using mAb a18 (Weiland et al., 1990 ; Kosmidou et al., 1995) . The STE cell line was grown in 40 % MEM-NEAA (Gibco BRL), 40 % Leibovitz's -15 medium (Gibco BRL), 10 % tryptose phosphate broth, 10 % horse serum, 100 IU\ml penicillin and 0n1 mg\ml streptomycin sulphate. All cells were incubated at 37 mC in a humidified atmosphere containing 5 % CO # .
Synthesis and analysis of synthetic peptides. A collection of 573 peptides spanning 82 % of the amino acid sequence of the CSFVGlentorf protein coding regions were synthesized using solid-phase multiple peptide synthesis (Jung & Beck-Sickinger, 1992 ) on a fully automated synthesizer (Syro). The 15-mer peptides, which overlapped each other by 10 residues, were prepared by solid-phase peptide synthesis using Fmoc\tBu chemistry. Syntheses were carried out on pbenzyloxybenzyl alcohol resin loaded with the first amino acid. The resin was distributed in 20-35 mg aliquots (15 µmol) to filter tubes positioned in a valve block. Fmoc deprotections were carried out with 50 % piperidine in dimethylformamide (DMF). Washing steps were done with DMF. Double couplings (1 h each) were performed with Fmoc amino acids in 10-fold excess and 1-hydroxybenzotriazole\diisopropylcarbo-diimide activation in DMF. Coupling reagents were filtered off and the resins were washed with DMF. Peptides were cleaved from the resins and side chain-deprotected with trifluoroacetic acid : phenol : ethanedithiol : thioanisole : water (82n5:5:2n5 : 5 : 5) for 3 h. Products were filtered from the resins and precipitated at k20 mC by the addition of diethylether. Precipitates were washed twice by sonication in diethylether and lyophilized from water : tert-butyl alcohol (1 : 4). The identity of each peptide was confirmed by electrospray mass spectrometry (triplequadrupol, Micromass) and most of the peptides were greater than 70 % pure, as determined by reverse-phase high-pressure liquid chromatography (Gynkotek) at 214 nm. All peptides (1 mg\ml) were dissolved in 1 % DMSO in water as a stock solution (stored at k20 mC) and further diluted in culture medium.
Isolation of PBMCs.
Infected pigs were bled every 1 or 2 weeks after the first infection. PBMCs were separated using density gradient centrifugation, as described previously (Summerfield et al., 1996) . Cells were frozen and stored in liquid nitrogen until use.
Lymphoproliferation assays. For the detection of CSFV-specific proliferation, PBMCs (10& cells per well) derived from CSFV-infected pigs were cultivated in MEM α-medium supplemented with 10 % FCS, 2 mM -glutamine, 0n05 mM 2-mercaptoethanol, 10 mM HEPES, 100 IU\ml penicillin and 0n1 mg\ml streptomycin sulphate as quadruplicates in 96-well round-bottom microplates (Greiner).
Cells were stimulated either with virus (10% TCID &! CSFV-Alfort\187 or 5i10% TCID &! CSFV-Glentorf per well) or with synthetic peptides (12n5 and 25 µg\ml). After incubation for 5 days at 37 mC in 5% CO # , proliferative responses were determined by adding [methyl-$H]thymidine for 18 h to the cultures (1 µCi per well) (Amersham). Cells were collected using a cell harvester system (Inotech). Incorporation of [$H]thymidine was measured in a Microbeta 1450 β-counter (Wallac). Results were expressed as stimulation indexes (SI), defined as the mean c.p.m. of stimulated cultures\mean c.p.m. of control cultures. The response was considered to be positive when the SI was 2.
Inhibition of CSFV-derived peptide-specific proliferation.
For the determination of MHC restriction of the presentation of peptide 290, mAbs directed against the porcine CD4 (mAb 74-12-4), CD8 (mAb 11\295\33), MHC class I (mAb 74-11-10) and MHC class II (mAb MSA3) molecules were added to the cultures to test their capacity to inhibit peptide-specific proliferation of CSFV-primed PBMCs. Thus, PBMCs were incubated with the appropriate dilution of mAb (hybridoma supernatant anti-CD4, anti-CD8, anti-MHC class I or anti-MHC class II) for 2 h before use in proliferation assays, as described previously (Summerfield et al., 1996) . Cytotoxicity assays. A chromium-release assay was used to measure CTL responses. CSFV-specific CTLs were generated by in vitro restimulation with virus (5i10% TCID &! CSFV-Glentorf per well) for 6 days in 96-well round-bottom microplates.
MAX cells infected with CSFV-Glentorf at an m.o.i. of 1 for 48 h were used as target cells in cytotoxicity assays. Then, 1i10' target cells were labelled with 100 µCi Na # &"CrO % (Amersham) for 1 h at 37 mC in 5% CO # . After washing, cells were resuspended in cell culture medium. For CTL experiments with peptides, 4i10% non-infected chromium-labelled target cells were incubated at 37 m C and 5 % CO # with 20 µg of the FFC T-cell epitopes of CSFV T-cell epitopes of CSFV respective peptides for 1 h. CSFV-infected or peptide-loaded target cells (1i10$ cells per well) were added to various concentrations of effector cells (ranging from 1n25i10% to 5i10% cells per well). All experiments were performed in triplicate cultures. Cells were centrifuged at 100 g for 5 min and incubated for 4 h at 37 mC in 5% CO # . After pelleting the cells at 600 g for 10 min, the chromium levels in the supernatants were measured using a Cobra Autogamma γ-counter (Packard). The percentage of specific cytolytic activity was calculated as follows : [(c.p.m. experimental release)k(c.p.m. spontaneous release)\(c.p.m. total release)k (c.p.m. spontaneous release)]i100. Mock-infected or negative peptideloaded target cells served as the controls.
Interferon (IFN)-γ ELISPOT assay. The ELISPOT assay was used to enumerate CSFV-and peptide-specific IFN-γ-secreting cells. For this, 96-well nitrocellulose plates (Millipore) were coated with 100 µl per well of mouse anti-pig IFN-γ mAb (5 µg\ml) (Endogen) diluted in PBS. After overnight incubation at 4 mC, wells were washed with PBS and incubated with 200 µl of MEM α-medium for 1 h at room temperature. Different concentrations of PBMCs from CSFV-infected pigs (ranging from 1n25i10& to 1i10' cells per well) were added in duplicate (each 100 µl) to the antibody-coated plates and incubated with 100 µl CSFV (2i10% TCID &! CSFV-Alfort\187 or 5i10% TCID &! CSFV-Glentorf per well) for 48 h. In peptide-sensitization experiments, 1i10' PBMCs per well (100 µl) were incubated with 100 µl of various concentrations of peptides (ranging from 5 to 100 µg\ml). PBMCs incubated with supernatant of mock-infected cells or irrelevant peptide 5 served as the negative controls.
After incubation at 37 mC in 5% CO # for 48 h, wells were washed with PBS and incubated with 100 µl of rabbit anti-pig IFN-γ polyclonal antibody (2n5 µg\ml) (Endogen) for 1 h at room temperature.
After washing with PBS, 100 µl per well of goat anti-rabbit peroxidase-conjugated IgG (Dianova) at a 1 : 200 dilution in PBS was added. After an additional 1 h of incubation at room temperature, wells were washed with PBS. For the development of IFN-γ-specific spots, 3,3h-diaminobenzidine (Sigma) was added for 4-7 min at room temperature. The colorimetric reaction was stopped by washing the plates with PBS and then water. After drying at room temperature, coloured spots were counted using a stereomicroscope at a 40-fold magnification. Analyses were repeated three times ; the SE between these repeats was less than 10 %.
Results

Proliferative responses of PBMCs to CSFV
Two inbred pigs (d\d haplotype) were infected with different strains of CSFV. To control the cellular immune response to the virus, blood samples were collected before and after (eight times at intervals of 2-3 weeks p.i.) infection. PBMCs were tested for their specific proliferative responses to CSFV in proliferation assays. PBMC proliferation was found to be both time-and dose-dependent ( Fig. 1a and b, respectively) . Specific responses of PBMCs from CSFV-infected pigs were observed at about 30 days p.i. No stimulation was observed with PBMCs collected from the swine prior to infection (day 0). An optimal stimulation of PBMCs could be induced with virus at an m.o.i. of 0n16-2n5 for strain Alfort\187 and at an m.o.i. of 0n1-4 for strain Glentorf. Results from kinetic experiments suggest that the culture conditions were optimum when [$H]thymidine incorporation was initiated 5 days after stimulation with CSFV (Fig. 1c) . PBMCs from the non-infected pigs showed no specific CSFV proliferation in the presence of CSFV.
Proliferative responses of PBMCs to CSFV-Glentorfderived peptides
To characterize the T-cell epitopes responsible for CSFV antigenicity, a set of 573 pentadecapeptides, each one (Meyers & Thiel, 1996) . The locations of the stimulating peptides in the viral polyprotein are shown. (b) PBMCs at 76 days p.i. from a CSFV-Glentorf-infected pig were tested for in vitro proliferation to 573 synthetic peptides (12n5 and 25 µg/ml). The SI of 26 peptides, which were identified as T-cell epitopes in proliferation assays, are plotted against the peptide number. (c) The stimulating peptides were tested further with PBMCs at 63 days p.i. from a CSFV-Alfort/187-infected pig. The irrelevant peptide 5 (N, EEPVYDATGRPLFGD) served as the negative control. Results represent the SI at the peptide concentration giving optimal stimulation. The error bars indicate SD. The sequences of the peptides are summarized in Table 1. overlapping the previous one by 10 amino acids, was synthesized. The peptides covered the amino acid sequence of the following CSFV-Glentorf proteins : N pro , C, E rns , E1, E2, p7, NS2-3, NS4A, NS4B and part of NS5A. The in vitro proliferative response of PBMCs to the CSFV peptides was studied at 76 days p.i. for a pig infected with CSFV-Glentorf (Fig. 2b ) and 63 days p.i. for a pig infected with CSFVAlfort\187 (Fig. 2c) The 26 sequences containing T-cell epitopes for CSFV-Glentorf, as identified in proliferation assays, are shown. Stimulating peptides for both infected pigs are underlined, whereas differences in the amino acid sequence of strains Glentorf and Alfort\187 are indicated in bold. The amino acid positions spanned by each peptide in the CSFV polyprotein and the genetic location of the peptide in each viral CSFV protein are shown. The underlined amino acid sequences indicate the CTL epitope described by Pauly et al. (1995) .
Peptide no.
Residues Location Amino acid sequence (strain Glentorf) Alfort/187
assays showed that stimulation with CSFV-derived peptides induces a significant proliferation of PBMCs between day 4 and day 5 post-stimulation. The optimal time for determination of the proliferative response of PBMCs was day 5 (data not shown). The proliferative responses of PBMCs to the CSFVderived peptides proved to be dose-dependent and, after titration experiments (data not shown), 12n5 and 25 µg\ml of each pentadecapeptide were tested in proliferation assays. A peptide with an SI 2 was identified as stimulatory. For the CSFV-Glentorf-infected pig, 26 of 573 peptides induced a significant proliferative response in PBMCs compared to spontaneous proliferation (Fig. 2b) . A total of 18 peptides stimulated PBMCs from both animals infected either with CSFV-Glentorf or with CSFV-Alfort\187 ( Fig. 2 and Table 1 ). With PBMCs isolated prior to infection, no specific reactivity to the stimulating peptides was detected. A variation between the proliferative responses of PBMCs from the pigs to the individual peptides was observed (Fig. 2) . The highest levels of specific proliferation of PBMCs to some peptides were found for the animal infected with CSFV-Glentorf. The location of the T-cell epitopes on the CSFV genome is shown in Fig. 2(a) . CSFV-Glentorf (GenBank accession no. U45478) and CSFVAlfort\187 (GenBank accession no. X87939) showed 98n2% identity with respect to the amino acid sequence of the peptides. Interestingly, peptides 77 (E rns ), 82 (E rns ), 114 (E1), 148 (E2), 290 (NS2-3), 296 (NS2-3), 470 (NS4B) and 561 (NS5A) showed differences in amino acid sequence between strains Glentorf and Alfort\187 (Table 1 ). In spite of the difference in their sequence, most of the peptides were able to induce significant proliferation of PBMCs from both animals. Only peptide 77 (E rns ) showed a lack of stimulating capacity with PBMCs from swine infected with CSFV-Alfort\187. A difference of one amino acid in the sequence between these two strains ( stimulating capacity of this peptide. The behaviour of peptides 133 (E1), 134 (E1), 287 (NS2-3), 336 (NS2-3), 407 (NS2-3), 457 (NS4A), 536 (NS4B-NS5A) was conspicuous : these peptides were not able to stimulate PBMCs derived from the CSFV-Alfort\187-infected pig although they showed no difference in the amino acid sequence between strains Glentorf and Alfort\187.
Peptide 290, which is derived from NS2-3, plays an immunodominant role in both animals and always showed the highest stimulation capacity in proliferation assays.
Secretion of IFN-γ
To confirm the reactivity of CSFV-specific T-cells against CSFV antigens, porcine T-cells were tested for their ability to produce IFN-γ upon virus as well as peptide stimulation in ELISPOT assays. These assays enable the detection of IFN-γ release on a single cell level and a determination of T-cell frequencies. First, the number of cells releasing IFN-γ was detected by spot formation in the presence of different strains of CSFV (Fig. 3a, c) . Various concentrations of PBMCs (ranging from 1n25i10& to 1i10' cells per well) from CSFV-infected swine were tested. The mean number of spots increased with an increasing amount of cells. For spot detecting, 1i10' cells per well were considered to be appropriate. The release of IFN-γ was CSFV-specific, as PBMCs incubated with supernatant from mock-infected cells presented only a few spots. High numbers of IFN-γ-secreting cells were observed when PBMCs from infected pigs were stimulated with peptide 290 (Fig. 3b,  d ). The number of cells releasing IFN-γ in response to peptide 290 was higher with PBMCs from swine infected with CSFVGlentorf compared with the PBMCs from swine infected with CSFV-Alfort\187. The release of IFN-γ by peptide 290 was shown to be sequence-specific, as only a few spots were observed after incubation of PBMCs with an irrelevant peptide. These results are an additional indication for an immunodominant role of peptide 290.
MHC restriction of the lymphoproliferative response to CSFV peptide 290
Virus-specific CD8 + CTLs recognize viral peptides presented by MHC class I molecules. In contrast, the peptide MHC class II complexes are recognized by virus-specific CD4 + helper T-cells. This interaction between T-cell receptor, MHC and accessory molecules (CD4 and CD8) can be blocked by the addition of mAbs against these surface molecules. To analyse the MHC restriction of the proliferative response to peptide FFG T-cell epitopes of CSFV T-cell epitopes of CSFV 290, we used mAbs against CD4, CD8, MHC class I and MHC class II molecules. The specific proliferative response could be blocked by an anti-MHC class II mAb as well as by an anti-CD4 mAb (Fig. 4 ). However, a lower level of inhibition of proliferation using anti-CD8 and MHC class I antibodies could also be observed. In conclusion, peptide 290 was able to stimulate helper T-cells as well as CD8 + cytotoxic T-cells.
CSFV-specific CTL response
To analyse the cytolytic activity of CSFV-specific CTLs, virus-restimulated PBMCs derived from the CSFV-Glentorfinfected pig were tested for their ability to lyse target MAX cells . Their activity was determined by the lysis of chromium-labelled CSFV-infected or peptide 290-loaded target cells (Fig. 5) . For the generation of CSFV-specific CTLs, PBMCs derived from the infected animals were cultivated for 6 days in vitro in the presence of CSFV. These CTLs elicited a strong cytolytic activity against target cells infected previously with the virus (Fig. 5a ). Furthermore, a significant cytolytic response against peptide 290-loaded MAX cells was observed (Fig. 5b) . Mock-infected target cells or target cells loaded with an irrelevant peptide (peptide 5), which were both used as negative controls, were not lysed by the CSFV-specific CTL effector cells. The peptides were non-toxic to the cells, as the level of spontaneous chromium release of target cells incubated with or without the irrelevant peptide was similar. In conclusion, target cells incubated with peptide 290 were recognized by CSFV-specific CTLs. Peptide 290 presented by d\d haplotype MHC class I molecules, which was characterized as MHC class II-restricted, could also be detected by CSFV-specific CTLs.
Discussion
The study of the cellular immune response to CSFV in the natural host is of utmost importance for understanding the interaction between the pathogen and the swine immune system. This is the basis for the development of vaccines to control virus infection. In this work, virus-specific T-cell responses were studied using PBMCs derived from CSFVinfected d\d haplotype swine, which were restimulated in vitro either by CSFV or by synthetic peptides. Pentadecapeptides were selected for use, as MHC class II molecules bind peptides of 10-30 amino acids in length (Chicz et al., 1993) . Screening of 82 % of the amino acid sequence of CSFV using these overlapping pentadecapeptides yielded 26 stimulating peptides, when investigated with PBMCs from a CSFV-Glentorfinfected pig. Eleven stimulating peptides were located in the region encompassing the structural proteins E rns , E1 and E2 and 15 peptides were identified on the non-structural proteins NS2-3, NS4A, NS4B and NS5A. The stimulating peptides 455 and 456 on the non-structural protein NS4A were reported previously to contain an MHC class I-restricted epitope . Obviously, E rns , E1, E2, NS2-3, NS4A, NS4B and NS5A proteins are important targets for the cellular immune response, since peptides derived from these proteins showed a CSFV-specific immune response. No stimulating peptides could be identified on the proteins N pro , C and p7.
Of the 26 stimulating peptides derived from CSFV-Glentorf proteins, 18 induced a proliferative response in lymphocytes from a CSFV-Alfort\187-infected pig.
Of interest is the finding that the MHC d\d haplotype recognized common T-cell epitopes in both inbred swine. Otherwise, some peptides (e.g. peptides 133 and 134) with an identical amino acid sequence between both strains (Glentorf and Alfort\187) were recognized as T-cell epitopes only with PBMCs from one pig. This MHC-independent preference for epitopes may have been caused either by host factors or by specific virus factors. This point might be the content of further studies.
Five of the common T-cell epitopes (peptides 140, 148,162, 200 and 201) were located on the E2 protein. The E2 glycoprotein is the most antigenic glycoprotein of CSFV and an immune response against E2 alone was reported to be sufficient for protection against CSFV (van Zijl et al., 1991 ; Hulst et al., 1993 ; Ko$ nig et al., 1995) . Our findings confirmed the striking antigenicity of this viral protein to induce an immune response. The stimulating peptides 200 and 201 derived from the E2 region are part of a B-cell epitope described previously (Yu et al., 1996) . The overlap of B-and Tcell epitopes in the same protein region has been described for FFH E. Armengol and others E. Armengol and others other viral antigens (Rodriguez et al., 1994) . Peptide vaccines encompassing B-and T-cell epitopes can result in the enhancement of antibody responses (Borra! s-Cuesta et al., 1987 ; Collen et al., 1991) .
The pentadecapeptide 290, which is derived from NS2-3, showed the highest SI in all proliferation assays performed. The reactivity of PBMCs against this peptide was thus characterized further. To analyse the virus-and peptideinducible production of IFN-γ from T-cells on a single cell level, ELISPOT assays were carried out. Advantages of the ELISPOT assay include sensitivity and efficiency in the detection of antigen-specific T-cells at the single cell level (Tanguay & Killion, 1994) . However, T-cell responses detected with this assay are limited to the T-cells that secrete IFN-γ. This assay represents a useful tool for the ex-vivo determination of frequencies of antigen-specific T-cells. It is known that CD4 + T-cells (Th1) as well as CD8 + T-cells are able to produce IFN-γ. In this study, virus-specific (CSFV-Glentorf and -Alfort\187) and peptide-specific (peptide 290) IFN-γ release were detected by ELISPOT assay.
In order to characterize peptide 290-specific T-cells, the MHC restriction of the proliferative response to this peptide was determined. Proliferation in the presence of peptide 290 was inhibited principally by anti-MHC class II and anti-CD4, confirming an MHC class II restriction. However, a partial inhibition of proliferation of PBMCs was also observed with anti-MHC class I and anti-CD8 antibodies.
This MHC class I restriction of the pentadecapeptide 290 was tested in CTL assays for the capacity of the peptide to elicit cytotoxic T-cell responses. Virus-specific CTLs were tested against MAX cells loaded with peptide 290. The results indicated the presence of a CTL epitope in the sequence of peptide 290. Thus, peptide 290 has the capacity to prime both MHC class I and class II-restricted T-cells. The sequence encoded a helper T-cell and a CTL epitope, representing a multideterminant peptide. This protein region spanning amino acids 1446-1460 (peptide 290) is highly conserved among the different CSFV strains.
Lytic activities of CTLs against target cells infected with CSFV were higher than those found against target cells loaded with peptide 290. Indeed, this fact can be explained due to the presence of additional and more active CTL epitopes on the virus. CTLs usually recognize peptide fragments from 8 to 11 amino acid residues in length bound to an MHC class I molecule (Falk et al., 1991) , but it has also been described that longer peptides could be recognized by CTLs (Bertoletti et al., 1993 ; Pauly et al., 1995) .
In conclusion, we have defined new T-cell epitopes on CSFV proteins. Peptide 290 on the NS2-3 protein has the capacity to elicit both CD4 + and CD8 + T-cell responses, suggesting that this protein segment may be a potential candidate for a synthetic peptide vaccine. Induction of CTL responses can be potentiated by covalent linkage of CTL and helper T-cell epitopes (Partidos et al., 1996 ; Shirai et al., 1994 ; Stuhler & Walden, 1993) . Candidate sequences for synthetic peptide vaccines should be conserved among different CSFV strains, binding diverse MHC molecules (Kubo et al., 1994 ; Oldstone et al., 1992) and contain helper T-cell, CTL and B-cell epitopes (An & Whitton, 1997) .
